CA2858427A1 - Procede de traitement du cancer par administration de faibles taux de proteine de choc thermique 70 (hsp70) - Google Patents
Procede de traitement du cancer par administration de faibles taux de proteine de choc thermique 70 (hsp70) Download PDFInfo
- Publication number
- CA2858427A1 CA2858427A1 CA2858427A CA2858427A CA2858427A1 CA 2858427 A1 CA2858427 A1 CA 2858427A1 CA 2858427 A CA2858427 A CA 2858427A CA 2858427 A CA2858427 A CA 2858427A CA 2858427 A1 CA2858427 A1 CA 2858427A1
- Authority
- CA
- Canada
- Prior art keywords
- hsp70
- tumors
- carcinoma
- administered
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261583535P | 2012-01-05 | 2012-01-05 | |
US61/583,535 | 2012-01-05 | ||
PCT/US2013/020252 WO2013103792A2 (fr) | 2012-01-05 | 2013-01-04 | Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70) |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2858427A1 true CA2858427A1 (fr) | 2013-07-11 |
Family
ID=48745538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2858427A Abandoned CA2858427A1 (fr) | 2012-01-05 | 2013-01-04 | Procede de traitement du cancer par administration de faibles taux de proteine de choc thermique 70 (hsp70) |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2800577A2 (fr) |
JP (1) | JP2015515445A (fr) |
AU (1) | AU2013207466A1 (fr) |
CA (1) | CA2858427A1 (fr) |
IL (1) | IL232732A0 (fr) |
WO (1) | WO2013103792A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202019398A (zh) * | 2018-06-28 | 2020-06-01 | 張翔毓 | 用於治療或預防構形疾病之方法及藥物篩選方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59912185D1 (de) * | 1998-03-27 | 2005-07-21 | Multhoff Gabriele | Verwendung von hsp70 protein |
HUE025852T2 (en) * | 2008-06-26 | 2016-04-28 | Orphazyme Aps | Use of HSP70 to regulate enzyme activity |
-
2013
- 2013-01-04 JP JP2014551330A patent/JP2015515445A/ja active Pending
- 2013-01-04 CA CA2858427A patent/CA2858427A1/fr not_active Abandoned
- 2013-01-04 EP EP13733755.6A patent/EP2800577A2/fr not_active Withdrawn
- 2013-01-04 AU AU2013207466A patent/AU2013207466A1/en not_active Abandoned
- 2013-01-04 WO PCT/US2013/020252 patent/WO2013103792A2/fr active Application Filing
-
2014
- 2014-05-21 IL IL232732A patent/IL232732A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2015515445A (ja) | 2015-05-28 |
AU2013207466A1 (en) | 2014-06-12 |
WO2013103792A2 (fr) | 2013-07-11 |
IL232732A0 (en) | 2014-07-31 |
EP2800577A2 (fr) | 2014-11-12 |
WO2013103792A3 (fr) | 2015-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maverakis et al. | Metastatic melanoma–a review of current and future treatment options | |
Butowski et al. | A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) | |
Moertel et al. | CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy | |
Habashy et al. | Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them | |
Cowawintaweewat et al. | Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment | |
KR101183705B1 (ko) | 암의 치료제 | |
Carvalho | Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial | |
Weide et al. | Intralesional treatment of metastatic melanoma: a review of therapeutic options | |
Ashrafi et al. | Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model | |
Gerber et al. | Local expression of interleukin‐2 by B16 melanoma cells results in decreased tumour growth and long‐term tumour dormancy | |
AU2013249522A1 (en) | Multivalent breast cancer vaccine | |
JP2021535083A (ja) | Cd80細胞外ドメインfc融合タンパク質投与レジメン | |
Wang et al. | Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment | |
Medikonda et al. | Immunotherapy as a new therapeutic approach for brain and spinal cord tumors | |
US20210363224A1 (en) | IL13Ra2 PEPTIDE AND ITS USES | |
US20200000899A1 (en) | Pharmaceutical composition for use in the treatment of cancer | |
TW202128212A (zh) | 一種具緩解抗癌藥物抗藥性及增加抗癌藥物敏感性之醫藥組合物及其用途 | |
CA2858427A1 (fr) | Procede de traitement du cancer par administration de faibles taux de proteine de choc thermique 70 (hsp70) | |
US20140194368A1 (en) | Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70) | |
CN105025916B (zh) | 抗分泌因子(af)在胶质母细胞瘤治疗中的用途 | |
US20190290776A1 (en) | Non-adult human dosing of anti-cd30 antibody-drug conjugates | |
US11946094B2 (en) | Combination therapies and methods of use thereof | |
CN101224297A (zh) | 重组人血管内皮抑制素在制药中的应用 | |
Gao et al. | Tumoral IL-10-activated SHP2 in macrophages promotes mammary carcinoma progression | |
CN113382744A (zh) | 操作脑膜淋巴管用于脑和cns肿瘤治疗 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20140918 |
|
FZDE | Discontinued |
Effective date: 20160105 |